<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a retrospective analysis of 113 patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) diagnosed according to French-American-British (FAB) classification, we evaluated the prognostic impact of FAB and World Health Organisation (WHO) classifications, International Prognostic Scoring System (IPSS), and other clinical and laboratory variables </plain></SENT>
<SENT sid="1" pm="."><plain>The median age was 69 </plain></SENT>
<SENT sid="2" pm="."><plain>IPSS could be applied to 75 patients classified according to the FAB criteria and to 50 patients reclassified according to the WHO criteria </plain></SENT>
<SENT sid="3" pm="."><plain>At a median follow-up of 24 months, 22 patients (19.5 %) transformed to <z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Overall survival (OS) of patients differed significantly between the FAB and WHO subgroups (p &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>In WHO classification, significant differences were observed in both OS and <z:mpath ids='MPATH_336'>leukaemia</z:mpath> free survival (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>) between patients with RA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> and refractory cytopenia with multi-lineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/refractory cytopenia with multi-lineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and ringed sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>/RS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>) (p = 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>High-risk according to IPSS score and blood transfusion need were significantly predictive for a shorter survival and higher risk of transformation </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> &lt;10 g/dl, neutrophil count &lt;0.5 x 10(9)/L, platelet count &lt;50 x 10(9)/L had an unfavourable prognostic impact on survival in multi-variate analysis </plain></SENT>
<SENT sid="8" pm="."><plain>Our conclusions support the previous findings on the value of WHO classification for prediction of prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>